AstraZeneca and Regeneron to develop obesity treatmentsAstraZeneca has entered into a collaboration with Regeneron to research, develop and commercialise small molecule compounds directed...
GLP-1s associated with higher risk of major depression, increased risk for anxiety and an elevated risk for suicidal behaviour22 hours ago